A multidisciplinary group aimed to advance the education, clinical care, & research involving pediatric & adult patients with immuno-hematologic disorders
Dr Nick Rider leading Project ECHO into the field of primary immune disorders - assuring excellent educational opportunities for rural practitioners. PEPI @nicerconsortium
Trainees: learning biochemistry IS an important part of being a physician! Thanks to Dr Charlie Billington for giving @nicerconsortium Metabolic Primer
Stump the Professor @nicerconsortium session is always EXCELLENT - to be able to see how these brilliant minds consider patient presentation, diagnostic testing and working through the differential diagnosis
Proof that a Wolverine (Dr Nathan Lake, PharmD) and a Buckeye (Dr Rob Baiocchi, Adult Hematology) CAN work together! Great breakout session on Crowd sourcing solutions for High Risk/High Cost Drugs @nicerconsortium
G6PC3 deficiency goes way beyond neutropenia! Thanks to Dr Ruben Martinez Barricarte. Impaired glycolysis in T cells and alteration of lipid uptake. @nicerconsortium
Kicking off the first session of @nicerconsortium was Dr. Troy Torgerson. Spectacular review of the activation, regulation and resolution mechanisms of the immune system that are used to respond to pathogens without responding to self. Look at that toolbox!
Purine metabolism from Dr Eyal Grunebaum. Deficiency or dysfunction of proteins like ADA, ADA2, AK2 and PNP result in not just #immunohematology abnormalities but in systemic disease - clinicians should be aware in settings of Neuro, Pulm, Hepatic presentations @nicerconsortium
Register Now:
https://t.co/oyVK1rFgly
Seize the opportunity to benefit from the early bird special before it ends on June 30th. We eagerly anticipate a dynamic and enlightening event that will deepen our understanding of the relationship between metabolism and immuno-hematology.
Dr. David Frame, pharmacist, excellent educator, taking @nicerconsortium down the rabbit hole discussing the role of age, weight/BSA, protein binding, enzyme activators/inhibitors, hepatic/renal clearance, inflammation, impact of antibiotics etc on med mgmt
@nicerconsortium Pro-Con debate #1 re: chemotherapy vs targeted MEK inhibitors for management of LCH. Appreciate Drs. Olive Eikstein and Jennifer Blase presenting their sides.
Oh captain, my captain! Dr. Jim Connelly moderating this session with Dr. Kelly Walkovich, mentor for the most immunohematology trainees 😉 as Executive leaders of the @nicerconsortium
Pro-Con debate #2 re: PNH management. Excellent intro to complement inhibition by Dr. Irem Eldem, then Dr. Beth Thielen @thie0149 presented the safety with regard to infectious profile with proper vaccination and @saara_kaviany clearly lobbied for transplant. @nicerconsortium